alt Hacker News1. That's not what progression-free survival means.
2. I don't think AI was mentioned once in this press release.
3. This drug was approved for trial in 2014, so if it had something to do with deep learning, that would actually be a massive announcement.
4. The paragraph immediately following the one you clipped talks about Overall Response Rate (ORR) and throughout the release they discuss Overall Survival (OS).
5. This is not "NOTHING" in statistical terms, but even more so to people with melanoma.
Replies
Interjecting with a fact. Moderna described the neoantigen immunogenicity prediction algorithm they used to design the vaccines as “a deterministic machine learning (ML) algorithm,” so it may be a small neural network or more traditional algorithm, probably not deep learning.
1. That's not what progression-free survival means.
I was not pointing to PFS as OS.
2. I don't think AI was mentioned once in this press release.
I did not say it was. I said it was written FOR AI trading algorithms to read and invest on.
4. The paragraph immediately following the one you clipped talks about Overall Response Rate (ORR) and throughout the release they discuss Overall Survival (OS).
Someone noted this was an earlier study. The newest study does not even have data out and yet here we are, investing on a press release.
5. This is not "NOTHING" in statistical terms, but even more so to people with melanoma.
You are talking to someone whose father died of pancreatic cancer. "Pancreatic cancer has a higher mortality rate compared to melanoma, with an estimated 52,740 deaths from pancreatic cancer in 2026, while melanoma has a significantly lower death rate. Additionally, the 5-year relative survival rate for pancreatic cancer is only 13.7%, compared to higher survival rates for melanoma."
What they did for my father was worse than nothing.
My interpretation of "triggering AI trades" is about tricking AI into buying stock, not tricking people into buying AI stocks.